Strategic Partnerships Terasaki Institute actively pursues collaborations with academia and industry, including a 2026 tie-up with Keck Graduate Institute and a 2025 collaboration with the University of Maryland School of Pharmacy, plus NIH funding for transplantation research. This signals a strong appetite for joint research and development programs and contract research offerings, enabling us to position services such as translational research support, nanoparticle formulation, and regenerative medicine development as attractive options.

Nanoparticle Therapies The institute has demonstrated capabilities in nanoparticle therapies for obesity, injectable dermal fillers for wound healing, and organ transplantation research, indicating a pipeline of platform technologies and proof-of-concept products. This creates sales opportunities for licensing of nanoparticle delivery platforms, contract development and manufacturing, regulatory consulting, and preclinical testing services.

West Coast Access Based in Los Angeles with partnerships in California research ecosystems, Terasaki is well positioned to engage regional hospitals, medical centers, and universities for joint projects, clinical translation, and sponsored research programs, leveraging proximity to biotech hubs and access to local talent and facilities.

Funding and Scale With substantial revenue and ongoing grant activity, the organization has buying power for external services, lab equipment, analytical software, and informatics solutions, offering a route to upsell CRO services, high-end analytical assays, data management tools, and training programs for researcher teams.

Data Driven Capabilities The tech stack includes SAS, SQL, Vue.js and other modern tools, plus Blackbaud fundraising software and Microsoft Teams for collaboration, highlighting readiness for data heavy R&D workflows and partner enablement, enabling opportunities to sell analytics services, electronic lab notebook and LIMS solutions, and integration projects that streamline research operations.